US drug distribution and services group Cencora (NYSE: COR) said it has agreed to accelerate its acquisition of a controlling ...

French biopharma DBV Technologies has rewarded the faith of long-term investors with compelling pivotal Phase III results on ...

US venture firm MBX Capital has crossed $100 million in cumulative capital commitments to invest in early-stage biotech and ...

US biotech Nektar Therapeutics shares increased by 10% in pre-market trading following promising Phase IIb trial results.

Switzerland-based Topadur Pharma, a biotech company developing innovative therapies for vascular regeneration, has announced ...

German biotech T-CURX today announced the first closing of a $20 million (17.7 million) Series A financing with a syndicate ...

US clinical-stage oncology company NanOlogy has appointed David Arthur as chief executive, as it accelerates development of ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new indication for Dutch immunology company ...

US firms SandboxAQ and MapLight Therapeutics have entered into a strategic collaboration to discover and develop potential ...

Canadian biotech Oncolytics Biotech (Nasdaq: ONCY) has reported encouraging clinical and translational data for its oncolytic ...

Across major agencies, the past fortnight brought a steady cadence of regulatory decisions, committee opinions, and ...

Shanghai Scizeng Medical Technology, a subsidiary of Changchun GeneScience Pharmaceutical (GenSci), RTW Investments and ...